Abstract
Standardized exercise testing has almost become a routine procedure in pediatrics. However, exercise testing should only be performed when indications and contraindications for the procedure have been considered and experienced staff and adequate equipment for testing and emergency measures are available. Most tests are conducted in children aged 5 years or older using a treadmill or a cycle ergometer. Various test protocols are available. Most often, protocols requiring a maximal effort are employed. Criteria for a valid maximal test are a plateau in oxygen uptake despite an increase in exercise intensity, a heart rate near the predicted maximum, and a high respiratory exchange ratio. In children with pulmonary or cardiac diseases, these established criteria may not be valid. Exercise testing can be used to diagnose exercise-induced adverse events such as exercise-induced arrhythmias or bronchial constriction, to clarify the cause of a limited exercise capacity, to identify risks associated with exertion such as arterial hypoxemia, and to monitor the progression of an underlying health condition as well as the effects of treatment.
Keywords: Pediatric exercise testing, treadmill, cycle ergometer, exercise protocols, exercise intensity, exchange ratio, cardiac diseases, bronchial constriction, arterial hypoxemia, pulmonary conditions, physical activity, exercise-associated risks, cystic fibrosis
Current Respiratory Medicine Reviews
Title: How to Measure Exercise Performance
Volume: 7 Issue: 2
Author(s): Katharina Ruf and Helge Hebestreit
Affiliation:
Keywords: Pediatric exercise testing, treadmill, cycle ergometer, exercise protocols, exercise intensity, exchange ratio, cardiac diseases, bronchial constriction, arterial hypoxemia, pulmonary conditions, physical activity, exercise-associated risks, cystic fibrosis
Abstract: Standardized exercise testing has almost become a routine procedure in pediatrics. However, exercise testing should only be performed when indications and contraindications for the procedure have been considered and experienced staff and adequate equipment for testing and emergency measures are available. Most tests are conducted in children aged 5 years or older using a treadmill or a cycle ergometer. Various test protocols are available. Most often, protocols requiring a maximal effort are employed. Criteria for a valid maximal test are a plateau in oxygen uptake despite an increase in exercise intensity, a heart rate near the predicted maximum, and a high respiratory exchange ratio. In children with pulmonary or cardiac diseases, these established criteria may not be valid. Exercise testing can be used to diagnose exercise-induced adverse events such as exercise-induced arrhythmias or bronchial constriction, to clarify the cause of a limited exercise capacity, to identify risks associated with exertion such as arterial hypoxemia, and to monitor the progression of an underlying health condition as well as the effects of treatment.
Export Options
About this article
Cite this article as:
Ruf Katharina and Hebestreit Helge, How to Measure Exercise Performance, Current Respiratory Medicine Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339811794927860
DOI https://dx.doi.org/10.2174/157339811794927860 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Mass Spectrometry in the “Omics” Era
Current Organic Chemistry Geriatric Evaluation of Oncological Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Bioprocess and Bioreactor: Next Generation Technology for Production of Potential Plant-based Antidiabetic and Antioxidant Molecules
Current Medicinal Chemistry Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Smoking and Weight
Current Respiratory Medicine Reviews Risk Stratification of Dyslipidemia: Insights from the Framingham Study
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]
Current Vascular Pharmacology Editorial [Hot Topic:Angiogenesis Agents(Executive Editor: Cezary Marcinkiewicz)]
Current Pharmaceutical Design Mass Spectrometry-Based Metabolic Profiling
Current Metabolomics Drug Repurposing for the Treatment of Staphylococcal Infections
Current Pharmaceutical Design Surgical or Interventional Revascularization in Diabetic Patients with Coronary Artery Disease?
Current Diabetes Reviews Implications of Nanotechnology in Healthcare
Nanoscience & Nanotechnology-Asia Homocysteine-Lowering Treatment in Coronary Heart Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents New Technological Developments in the Clinical Imaging of Atherosclerotic Plaque
Current Pharmaceutical Design Influence of Statin Use on Endothelial Function: From Bench to Clinics
Current Pharmaceutical Design Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias
Current Pharmaceutical Design Markers of Arrhythmogenic Risk in Hypertensive Subjects
Current Pharmaceutical Design